Literature DB >> 7945800

Cancer gene therapy: a bystander effect using the gap junctional pathway.

J D Pitts1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7945800     DOI： 10.1002/mc.2940110302

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN： 0899-1987            Impact factor:   4.784


× No keyword cloud information.
  8 in total

Review 1.  Gene therapy. Clinical potential and relationship to drug treatment.

Authors:  K A Whartenby; A J Marrogi; S M Freeman
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

Review 2.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

3.  Solute exchange through gap junctions lessens the adverse effects of inactivating mutations in metabolite-handling genes.

Authors:  Stefania Monterisi; Johanna Michl; Alzbeta Hulikova; Jana Koth; Esther M Bridges; Amaryllis E Hill; Gulnar Abdullayeva; Walter F Bodmer; Pawel Swietach
Journal:  Elife       Date:  2022-09-15       Impact factor: 8.713

4.  Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA.

Authors:  Y Kato; S Matsukawa; R Muraoka; N Tanigawa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus.

Authors:  N M Carroll; E A Chiocca; K Takahashi; K K Tanabe
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

6.  Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy.

Authors:  Sylvine Cottin; Karim Ghani; Pedro Otavio de Campos-Lima; Manuel Caruso
Journal:  Mol Cancer       Date:  2010-06-10       Impact factor: 27.401

7.  Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.

Authors:  Na-Kyung Han; Dae Hwan Shin; Jung Seok Kim; Kwon Yeon Weon; Chang-Young Jang; Jin-Seok Kim
Journal:  Int J Nanomedicine       Date:  2016-04-05

Review 8.  Connexins in cancer: bridging the gap to the clinic.

Authors:  Trond Aasen; Edward Leithe; Sheila V Graham; Petra Kameritsch; María D Mayán; Marc Mesnil; Kristin Pogoda; Arantxa Tabernero
Journal:  Oncogene       Date:  2019-02-27       Impact factor: 9.867
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.